Evidence map›Paper›PMID 37506307›Full record

ArticleAngewandte Chemie (International ed. in English)2023

Asymmetric Dearomatization of Phenols via Ligand-Enabled Cooperative Gold Catalysis.

Yongliang Zhang, Ke Zhao, Xinyi Li, Carlos D Quintanilla, Liming Zhang

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongliang ZhangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID http://orcid.org/0000-0002-6671-2495
Ke ZhaoDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID http://orcid.org/0000-0003-2301-490X
Xinyi LiDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID http://orcid.org/0009-0002-3151-033X
Carlos D QuintanillaDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID http://orcid.org/0009-0003-6879-3297
Liming ZhangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID http://orcid.org/0000-0002-5306-1515

Funding

Research Supplements to Promote Diversity in Health-Related ResearchR35GM139640 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Liming Zhang · 2021 to 2026
$2.5M
NIGMS NIH HHS R35 GM139640NIGMS NIH HHS R35GM139640ODCDC CDC HHS MRI-1920299
6 · The paper itself

Abstract

By employing a chiral bifunctional phosphine ligand, a gold(I)-catalyzed efficient and highly enantioselective dearomatization of phenols is achieved via versatile metal-ligand cooperation. The reaction is proven to be remarkably general in scope, permitting substitutions at all four remaining benzene positions, accommodating electron-withdrawing groups including strongly deactivating nitro, and allowing carbon-based groups of varying steric bulk including tert-butyl at the alkyne terminus. Moreover, besides N-(o-hydroxyphenyl)alkynamides, the corresponding ynoates and ynones are all suitable substrates. Spirocyclohexadienone-pyrrol-2-ones, spirocyclohexadienone-butenolides, and spirocyclohexadenone-cyclopentenones are formed in yields up to 99 % and with ee up to 99 %.

Indexed as

CyclizationDearomatizationEnantioselectivityGold CatalysisMetal-Ligand Cooperation

Identifiers

PMID37506307
PMCPMC10528085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.